Perspective Therapeutics (CATX) FCF Margin Growth (1y) (2011 - 2023)
Perspective Therapeutics (CATX) FCF Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 2,833.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | -125.00 |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 2,811.00 |
| 10 | Perspective Therapeutics | 303.56 Mn | 303.56 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -38,477.00 |
| Jun 30, 2023 | -49,303.00 |
| Mar 31, 2023 | -43,122.00 |
| Sep 30, 2022 | -493.00 |
| Mar 31, 2022 | -2,237.00 |
| Dec 31, 2021 | 13,302.00 |
| Sep 30, 2021 | -6,447.00 |
| Mar 31, 2021 | 400.00 |
| Dec 31, 2020 | 2,798.00 |
| Sep 30, 2020 | 1,352.00 |
| Jun 30, 2020 | 1,762.00 |
| Mar 31, 2020 | 4,474.00 |
| Dec 31, 2019 | 160.00 |
| Sep 30, 2019 | 7,806.00 |
| Jun 30, 2019 | 4,102.00 |
| Mar 31, 2019 | -239.00 |
| Dec 31, 2018 | 4,107.00 |
| Sep 30, 2018 | 3,112.00 |
| Jun 30, 2018 | 1,028.00 |
| Mar 31, 2018 | 4,624.00 |